Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
  • Users Online: 5827
  • Home
  • Print this page
  • Email this page

   Table of Contents      
CASE REPORT
Year : 1995  |  Volume : 43  |  Issue : 3  |  Page : 136-137

Childhood myasthenia gravis in a toddler


Department of Ophthalmology, Christian Medical College & Hospital, Ludhiana, India

Correspondence Address:
S G Jaison
Department of Ophthalmology, Christian Medical College & Hospital, Ludhiana 141 008
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


PMID: 8822490

Rights and PermissionsRights and Permissions

How to cite this article:
Jaison S G, Abraham AP. Childhood myasthenia gravis in a toddler. Indian J Ophthalmol 1995;43:136-7

How to cite this URL:
Jaison S G, Abraham AP. Childhood myasthenia gravis in a toddler. Indian J Ophthalmol [serial online] 1995 [cited 2020 Jun 5];43:136-7. Available from: http://www.ijo.in/text.asp?1995/43/3/136/25288

Myaesthenia gravis is defined as an acquired autoimmune disorder in which there is abnormal fatiguability of muscles due to deficiency of acetylcholine receptors caused by circulating antibodies directed against them. It can occur at any age but usually occurs after the age of five years.[1]

There are not many reports of childhood myasthenia gravis. Of the 13 cases of childhood myaesthenia gravis reported by Verma et al,[2] the youngest was 2 years at the onset of the illness. This case of childhood myaesthenia is being reported in view of its onset at 17 months of age.


  Case report Top


An 18-month-old female child presented with complaints of partial bilateral ptosis and inability to move the eyeballs, noted by the parents one month prior to reporting to us. The onset of the symptoms were gradual, and not preceded by any acute febrile illness. There was no history of difficulty in swallowing, chewing, or physical activity. No history of snake bite was given. The child was born normally at full-term to a healthy young mother and the perinatal period was uneventful. The milestones of the child were also normal. None of the siblings had similar complaints.

General physical examination revealed a female child of normal physical and mental development. She had bilateral partial ptosis. Visual axes were parallel. There was total bilateral external ophthalmoplegia [Figure - 1]. The cornea was normal. There was no cataract or pigmentary changes in the retina. There was no heart block, ataxia, areflexia, motor weakness or any other neurological deficits.

Based on the history and physical examination, a provisional diagnosis of childhood myaesthenia (Stage I) was made. A repetitive stimulation of the right median nerve at 3/sec demonstrated a significant decremental response in the amplitude of muscle action potential (18%), confirming the diagnosis of myaesthenia gravis. The child was subjected to a Neostigmine test which was unequivocally positive. Chest X-ray and other routine tests were normal. The child was started on tablet neostigmine 3 mg twice daily and tablet prednisolone 10 mg daily orally. At follow-up 3 weeks later, ocular motility was found to be fully restored and there was no ptosis. At six months follow-up the child had recurrence of symptoms while off treatment, but on restarting the treatment the child was restored to normal and is on regular follow-up till date [Figure - 2].


  Discussion Top


As this child presented with myaesthenia at an age below two years, familial infantile myaesthenia was considered; it was ruled out in absence of family history and involvement of extraocular muscles.

Congenital myaesthenia gravis described by Bowman[3] and Levin[4] was another possible diagnosis as the extraocular muscles were predominantly involved but congenital myaesthenia usually has familial occurrence and does not respond to steroid therapy.

Our patient was diagnosed to have juvenile myaesthenia,[5] a variant of adult myaesthenia with similar clinical presentation and autoimmune mechanism. The remarkable response of the child to systemic steroid therapy confirms the autoimmune mechanism. This case of childhood myaesthenia of the juvenile subtype in a female child is being reported for its rare occurrence at the early age of 17 months. To our knowledge, this is the youngest patient of childhood myaesthenia of the juvenile subtype reported so far.

 
  References Top

1.
Desai AD, Raju TNR, Deshpande DH. Muscles and their disorders. In: Textbook of Paediatrics, Vol. I, Udani PM, (ed). New Delhi, Jaypee Brothers, 1991, pp. 2232-2244.  Back to cited text no. 1
    
2.
Verma AK, Behari M, Ahuja GK. Myasthenia gravis in young. Indian J Paediatr 23:363-369, 1986.  Back to cited text no. 2
    
3.
Bowman JR. Myasthenia gravis in young children. Paediatrics 1:472-477, 1948.  Back to cited text no. 3
    
4.
Levin PM. Congenital myasthenia in siblings. Arch Neurol 62:745-748, 1949.  Back to cited text no. 4
    
5.
Millichap JG, Dodge PR. Diagnosis and treatment of myasthenia gravis in infancy, childhood and adolescence. Neurology 11:1007-1014,1960.  Back to cited text no. 5
    


    Figures

  [Figure - 1], [Figure - 2]



 

Top
 
 
  Search
 
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

 
  In this article
Case report
Discussion
References
Article Figures

 Article Access Statistics
    Viewed3543    
    Printed88    
    Emailed3    
    PDF Downloaded1    
    Comments [Add]    

Recommend this journal